KNSA News and Press, Kiniksa Pharmaceuticals Ltd. From 10/30/23

2023-10-30 11:27:11 ET More on Kiniksa Pharmaceuticals Kiniksa's Diversified Pipeline Augments Arcalyst Potential Seeking Alpha’s Quant Rating on Kiniksa Pharmaceuticals Historical earnings data for Kiniksa Pharmaceuticals Financial information for Kin...

HAMILTON, Bermuda, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 31, 2023 at 8:30 a.m. Eastern Time to report its third quarter 2023 financial results and recent portfolio...

2023-10-06 05:54:29 ET Summary Kiniksa's Arcalyst shows strong clinical efficacy in recurrent pericarditis, driving revenue potential conservatively estimated at $300-400 million. Solid financials, including a long cash runway and robust current ratio, add confidence; however, pat...

2023-07-27 10:57:33 ET Summary Shares of Kiniksa Pharmaceuticals surged after the company reported strong Q2 results and raised the full-year net sales guidance for Arcalyst. The strong growth and improved outlook were driven by the recent sales force expansion. I see Arcalyst...

2023-07-25 13:06:13 ET Shares of Kiniksa Pharmaceuticals (NASDAQ: KNSA) were up more than 27% just before noon on Tuesday after the company reported second-quarter earnings. The stock is up more than 27% so far this year. Kiniksa is a biotech company that focuses on therapie...

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is one of today's top gainers. The company's shares are currently up 29.35% on the day to $19.32. Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines fo...

2023-07-25 12:22:14 ET Kiniksa Pharmaceuticals Ltd (KNSA) Q2 2023 Q2 2023 Earnings Call Transcript July 25, 2023 8:30 AM ET Company Participants Rachel Frank - Associate Director of Investor Relations Sanj Patel - Chief Executive Officer Ross Moat - Senior VP &am...

2023-07-25 12:09:08 ET Gainers: Electra Battery Materials ( ELBM ) +72% . Bullfrog AI Holdings ( BFRG ) +38% . Kiniksa Pharmaceuticals ( KNSA ) +30% . Steakholder Foods ( STKH ) +25% . Galecto ( GLTO ) +23% . Rigetti Computin...

2023-07-25 10:18:59 ET Gainers: Bullfrog AI ( BFRG ) +35% . Carmell Therapeutics ( CTCX ) +32% . Kiniksa Pharmaceuticals ( KNSA ) +21% . Galecto ( GLTO ) +18% . Akebia Therapeutics ( AKBA ) +16% . Losers: NeuroOne Med...

2023-07-25 07:36:11 ET Kiniksa Pharmaceuticals press release ( NASDAQ: KNSA ): Q2 GAAP EPS of $0.21 beats by $0.38 . Revenue of $71.47M (+165.0% Y/Y) beats by $19.27M . Total revenue for the second quarter of 2023 included $54.5 million in ARCALYST net product ...